Cohance Lifesciences Limited — Updates, 27-04-2026: Press Release
27-04-2026 · 09:06 am
Cohance Lifesciences appointed Umang Vohra, ex-Cipla CEO, as Executive Chairman & Group CEO. This leadership change targets accelerating the company's transformation and growth as a CDMO platform, leveraging Vohra's extensive pharma experience.
No comments yet. Be the first to comment!
